TYRA
Tyra Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.93B
P/E Ratio
—
EPS
$-2.18
Beta
0.79
52W High
$40.65
52W Low
$8.75
50-Day MA
$35.91
200-Day MA
$24.60
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Tyra Biosciences Inc
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and improve outcomes for cancer patients. The company is headquartered in Carlsbad, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-142.37M |
| Operating Margin | 0.00% |
| Return on Equity | -36.90% |
| Return on Assets | -23.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $4.83 |
| Price-to-Book | 4.98 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -6.95 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $59.47M |
| Float | $30.93M |
| % Insiders | 2.86% |
| % Institutions | 111.39% |
Historical Volatility
HV 10-Day
44.21%
HV 20-Day
46.88%
HV 30-Day
46.15%
HV 60-Day
49.93%
HV Rank
4.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($51.15 target)
2
Strong Buy11
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026